Home LiteratureArticle Details
PMID: 3806791 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

A 14,000-Mr envelope protein of vaccinia virus is involved in cell fusion and forms covalently linked trimers.

Journal of virology ·Vol. 61 ·No. 2 ·1987-02-00 ·Pages 395-404

Rodriguez JF, Paez E, Esteban M

Abstract

A monoclonal antibody, MAbC3, that reacts with a 14,000-molecular-weight envelope protein (14K protein) of vaccinia virus completely inhibited virus-induced cell fusion during infection. Immunoblot and immunofluorescence studies revealed that the 14K protein was synthesized at about 6 to 7 h postinfection and transported from the cytoplasm to the cell surface. Synthesis and transport of the 14K protein during infection occurred in the presence of rifampin, an inhibitor of virus maturation. One- and two-dimensional gel electrophoretic analyses demonstrated that the 14K protein forms largely trimers (42K) that are covalently linked by disulfide bonds. The facts that MAbC3 prevents virus uncoating and blocks virus-induced cell fusion but does not prevent virus attachment to cells and the 14K envelope protein forms trimers all suggest that this protein plays major role in virus penetration.

MeSH Terms
Animals Antibodies, Monoclonal Cell Fusion Cell Line Chlorocebus aethiops Kidney Kinetics L Cells/cytology Macromolecular Substances Mice Molecular Weight Vaccinia virus/physiology Viral Envelope Proteins/biosynthesis,physiology
Chemicals
Antibodies, Monoclonal Macromolecular Substances Viral Envelope Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rodriguez J F
Paez E
Esteban M
References (23)
23 references, click to expand
  1. Complications of smallpox vaccination, 1968.
    N Engl J Med. 1969 Nov 27;281(22):1201-8 PMID: 4186802
  2. The purification fo four strains of poxvirus.
    Virology. 1962 Sep;18:9-18 PMID: 14036977
  3. Interruption by Rifampin of an early stage in vaccinia virus morphogenesis: accumulation of membranes which are precursors of virus envelopes.
    J Virol. 1970 Oct;6(4):519-33 PMID: 5497899
  4. The mode of entry of vaccinia virus into L cells.
    J Gen Virol. 1973 Dec;21(3):533-7 PMID: 4128637
  5. Biogenesis of vaccinia: isolation and characterization of a surface component that elicits antibody suppressing infectivity and cell-cell fusion.
    Virology. 1976 Nov;75(1):232-41 PMID: 982851
  6. Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion.
    Virology. 1979 Jun;95(2):385-94 PMID: 462799
  7. Identification of the vaccinia hemagglutinin polypeptide from a cell system yielding large amounts of extracellular enveloped virus.
    J Virol. 1979 Jul;31(1):147-55 PMID: 501796
  8. Adsorption and penetration of the trypsinized vaccinia virion.
    Virology. 1980 Feb;101(1):50-60 PMID: 7355578
  9. Biogenesis of vaccinia: carbohydrate of the hemagglutinin molecules.
    Virology. 1981 May;111(1):56-72 PMID: 7233832
  10. Proteolytic activation of vaccinia virus for the penetration phase of infection.
    Virology. 1982 Jan 15;116(1):297-305 PMID: 7064342
  11. Modification of membrane permeability in vaccinia virus-infected cells.
    Virology. 1982 Feb;117(1):62-9 PMID: 6175088
  12. Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.
    Proc Natl Acad Sci U S A. 1982 Aug;79(16):4927-31 PMID: 6289324
  13. Vaccinia virus: a selectable eukaryotic cloning and expression vector.
    Proc Natl Acad Sci U S A. 1982 Dec;79(23):7415-9 PMID: 6296831
  14. Defective vaccinia virus particles in interferon-treated infected cells.
    Virology. 1984 Feb;133(1):220-7 PMID: 6702105
  15. Generation of a dominant 8-MDa deletion at the left terminus of vaccinia virus DNA.
    Proc Natl Acad Sci U S A. 1985 May;82(10):3365-9 PMID: 2987924
  16. Vaccinia virus proteins on the plasma membranes of infected cells. II. Expression of viral antigens and killing of infected cells by vaccinia virus-specific cytotoxic T cells.
    Virology. 1985 Aug;145(1):1-23 PMID: 3874471
  17. Purification and characterization of vaccinia virus growth factor.
    Cell. 1985 Aug;42(1):383-93 PMID: 2410141
  18. Interferon prevents the generation of spontaneous deletions at the left terminus of vaccinia virus DNA.
    J Virol. 1985 Oct;56(1):75-84 PMID: 3861876
  19. Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus.
    J Virol. 1985 Nov;56(2):482-8 PMID: 4057358
  20. Epidermal growth factor receptor occupancy inhibits vaccinia virus infection.
    Nature. 1985 Dec 19-1986 Jan 1;318(6047):663-5 PMID: 3001528
  21. Vaccinia virus antigens on the plasma membrane of infected cells. I. Viral antigens transferred from infecting virus particles and synthesized after infection.
    Virology. 1985 Mar;141(2):201-20 PMID: 4082499
  22. Specific proteins synthesized during the viral lytic cycle in vaccinia virus-infected HeLa cells: analysis by high-resolution, two-dimensional gel electrophoresis.
    J Virol. 1986 May;58(2):569-77 PMID: 3701923
  23. Biogenesis of vaccinia: separation of early stages from maturation by means of rifampicin.
    Virology. 1970 Apr;40(4):1039-51 PMID: 4317898
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1987-02-00
Pages
395-404
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC253962
Subset
IM
Grants
NIAID NIH HHS · AI 16780 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]